Thermo Fisher partners EDB for US$130m sterile fill-and-finish facility
Add BT as a preferred source
Singapore
THERMO Fisher Scientific's plans to build a new US$130 million sterile fill-and-finish facility in Singapore, with the support of the Singapore Economic Development Board (EDB), will create some 300 jobs once operational in 2022.
The investment is an "important addition to the manufacturing capacity needed by global pharmaceutical and vaccine companies in the ongoing fight against Covid-19," EDB chairman Beh Swan Gin said in a press release late last week.
TRENDING NOW
Digital Realty, STT GDC among data centre operators awarded 50 MW of new capacity in Singapore
Jardine C&C selling Singapore, Malaysia dealerships to Indonesia’s Chandra Asri for US$221 million gain
When every phone becomes a satellite phone, what happens to Asia’s telcos?
‘How come you’re so young?’: Gen Z couple takes on Singapore’s established bullion dealers
